β-干扰素在多发性硬化症中的作用机制。 - Suppr

Mechanisms of action of interferon-beta in multiple sclerosis.

作者信息

Arnason B G, Dayal A, Qu Z X, Jensen M A, Genç K, Reder A T

机构信息

Department of Neurology and the Brain Research Institute, University of Chicago, IL 60637, USA.

出版信息

Springer Semin Immunopathol. 1996;18(1):125-48. doi: 10.1007/BF00792613.

DOI:10.1007/BF00792613

PMID:8984676

Abstract

摘要

相似文献

Mechanisms of action of interferon-beta in multiple sclerosis.

Springer Semin Immunopathol. 1996;18(1):125-48. doi: 10.1007/BF00792613.

Targets for the therapeutic action of interferon-beta in multiple sclerosis.

Ann Neurol. 1996 Dec;40(6):825-6. doi: 10.1002/ana.410400602.

[Interferon-1 beta in the treatment of multiple sclerosis].

Nervenarzt. 1995 Sep;66(9 Suppl Interferon):1-16.

Interferon beta treatment of multiple sclerosis.

Neurology. 1994 Jan;44(1):186; author reply 188-90. doi: 10.1212/wnl.44.1.186-a.

Interferon beta treatment of multiple sclerosis.

Neurology. 1994 Jan;44(1):186; author reply 188-90. doi: 10.1212/wnl.44.1.186-b.

Interferon beta treatment of multiple sclerosis.

Neurology. 1994 Jan;44(1):186; author reply 188-90. doi: 10.1212/wnl.44.1.186.

[Interferon beta and copolymer-1: mechanism of action and clinical effects in multiple sclerosis].

Neurol Neurochir Pol. 2000;34(3 Suppl):63-9.

[Advances in the therapy of multiple sclerosis with interferon beta-1a].

Nervenarzt. 1997 Oct;68(10 Suppl):1-8.

Interferon beta treatment of multiple sclerosis.

Neurology. 1994 Jan;44(1):188; author reply 188-90. doi: 10.1212/wnl.44.1.188.

Interferon beta-1a and beta-1b for treatment of multiple sclerosis.

Lancet. 2002 Nov 2;360(9343):1428; author reply 1428-9. doi: 10.1016/S0140-6736(02)11384-5.

引用本文的文献

Relationship between Neutrophil-to-Lymphocyte Ratio and Stress in Multiple Sclerosis Patients.

J Clin Diagn Res. 2017 May;11(5):CC01-CC04. doi: 10.7860/JCDR/2017/24388.9764. Epub 2017 May 1.

Disease-modifying therapies and infectious risks in multiple sclerosis.

Nat Rev Neurol. 2016 Apr;12(4):217-33. doi: 10.1038/nrneurol.2016.21. Epub 2016 Mar 4.

Induction of a unique isoform of the NCOA7 oxidation resistance gene by interferon β-1b.

J Interferon Cytokine Res. 2015 Mar;35(3):186-99. doi: 10.1089/jir.2014.0115. Epub 2014 Oct 20.

Interferon-beta-1b-induced short- and long-term signatures of treatment activity in multiple sclerosis.

Pharmacogenomics J. 2013 Oct;13(5):443-51. doi: 10.1038/tpj.2012.27. Epub 2012 Jun 19.

Multiple sclerosis-linked and interferon-beta-regulated gene expression in plasmacytoid dendritic cells.

J Neuroimmunol. 2012 Sep 15;250(1-2):99-105. doi: 10.1016/j.jneuroim.2012.05.013. Epub 2012 Jun 9.

The mechanism of action of interferon-β in relapsing multiple sclerosis.

CNS Drugs. 2011 Jun 1;25(6):491-502. doi: 10.2165/11591110-000000000-00000.

Chemotherapeutics in the treatment of multiple sclerosis.

Ther Adv Neurol Disord. 2010 Sep;3(5):277-91. doi: 10.1177/1756285610379885.

The influences of cytokines as a possible substrate for the psychological effects of immunomodulation therapy in multiple sclerosis.

Neurosci Behav Physiol. 2009 Jan;39(1):25-30. doi: 10.1007/s11055-008-9087-1.

N-acetyl-L-cysteine ameliorates the inflammatory disease process in experimental autoimmune encephalomyelitis in Lewis rats.

J Autoimmune Dis. 2005 May 3;2(1):4. doi: 10.1186/1740-2557-2-4.

Biological activity of interferon betas in patients with multiple sclerosis is affected by treatment regimen and neutralising antibodies.

J Neurol Neurosurg Psychiatry. 2004 Sep;75(9):1294-9. doi: 10.1136/jnnp.2004.037259.

本文引用的文献

Eicosenoids Modify Experimental Allergic Encephalomyelitis.

Am J Ther. 1995 Sep;2(9):711-720. doi: 10.1097/00045391-199509000-00020.

All-trans retinoic acid potentiates the ability of interferon beta-1b to augment suppressor cell function in multiple sclerosis.

Arch Neurol. 1998 Mar;55(3):315-21. doi: 10.1001/archneur.55.3.315.

Interferon-gamma-secreting cells in multiple sclerosis patients treated with interferon beta-1b.

Neurology. 1995 Dec;45(12):2173-7. doi: 10.1212/wnl.45.12.2173.

Validation of the functional assessment of multiple sclerosis quality of life instrument.

Neurology. 1996 Jul;47(1):129-39. doi: 10.1212/wnl.47.1.129.

Involvement of cytokines in acute neurodegeneration in the CNS.

Neurosci Biobehav Rev. 1993 Summer;17(2):217-27. doi: 10.1016/s0149-7634(05)80152-6.

Pharmacokinetics of recombinant human interferon-beta ser in healthy volunteers and its effect on serum neopterin.

Pharm Res. 1993 Apr;10(4):567-72. doi: 10.1023/a:1018902120023.

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group.

Neurology. 1993 Apr;43(4):662-7. doi: 10.1212/wnl.43.4.662.

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group.

Neurology. 1993 Apr;43(4):655-61. doi: 10.1212/wnl.43.4.655.

Interferon beta in multiple sclerosis.

Neurology. 1993 Apr;43(4):641-3. doi: 10.1212/wnl.43.4.641.

Multiple sclerosis: remyelination of nascent lesions.

Ann Neurol. 1993 Feb;33(2):137-51. doi: 10.1002/ana.410330203.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Mechanisms of action of interferon-beta in multiple sclerosis.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献